X-149487080-T-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000202.8(IDS):āc.1025A>Gā(p.His342Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,981 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H342P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000202.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IDS | NM_000202.8 | c.1025A>G | p.His342Arg | missense_variant | 8/9 | ENST00000340855.11 | |
IDS | NM_001166550.4 | c.755A>G | p.His252Arg | missense_variant | 8/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IDS | ENST00000340855.11 | c.1025A>G | p.His342Arg | missense_variant | 8/9 | 1 | NM_000202.8 | P1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097981Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363337
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-II Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 31, 2024 | Variant summary: IDS c.1025A>G (p.His342Arg) results in a non-conservative amino acid change located in the Sulfatase, N-terminal domain (IPR000917) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183468 control chromosomes. c.1025A>G has been reported in the literature in hemizygous brothers affected with Mucopolysaccharidosis Type II (Hunter Syndrome) (e.g. Lin_2020, Lin_2022). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in reduced IDS enzyme activity in patient leukocytes (50% of WT) or in vitro in COS-7 cells (42% of WT) (e.g. Lin_2020). Multiple different variants located at the same codon (c.1025A>C (p.His342Pro) and c.1024C>T (p.His342Tyr)) have been classified as likely pathogenic/pathogenic in ClinVar (ClinVar ID: 221972, 946154), both citing clinical evidence of variant occurrence in individuals affected with Mucopolysaccharidosis Type II (Hunter Syndrome), supporting a critical relevance of this residue to IDS protein function. The following publications have been ascertained in the context of this evaluation (PMID: 33096603, 35887520). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova | Jun 07, 2024 | Prevalence of the variant significantly increased in affected individuals compared with controls (PS4_Strong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Missense variant in a gene with a low rate of benign missense variation (PP2_Supporting), Multiple lines of computational evidence support a deleterious effect (PP3_Supporting) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at